Please try another search
| YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
|---|---|---|---|---|---|---|
| Growth of 1000 | 1035 | 1051 | 1075 | 1202 | 1142 | - |
| Fund Return | 3.54% | 5.12% | 7.5% | 6.32% | 2.69% | - |
| Place in category | 58 | 47 | 39 | 32 | 51 | - |
| % in Category | 32 | 26 | 22 | 18 | 29 | - |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| Arquiplan PP | 47.31M | 3.37 | 8.06 | 2.37 | ||
| Arquiplan Crecimiento | 17.41M | 8.26 | 14.50 | 6.45 | ||
| Arquiplan Conservador | 13.71M | 0.07 | 2.94 | 0.21 | ||
| Solventis Eos PP | 8.28M | 11.71 | 13.90 | 6.18 | ||
| Arquiplan Bolsa | 6.66M | 29.11 | 21.14 | 6.36 |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| CABK Equilibrio PP | 4.11B | 3.90 | 5.76 | 2.08 | ||
| Mi Plan Santander Moderado PP | 2.53B | 3.89 | 6.35 | 2.30 | ||
| BBVA Multiactivo Conservador PP | 2.26B | 2.33 | 4.25 | 1.19 | ||
| Mi Plan Santander Prudente PP | 1.52B | 2.31 | 4.34 | 0.41 | ||
| Mapfre Mixto PP | 846.16M | 5.62 | 5.50 | 2.16 |
| Name | ISIN | Weight % | Last | Change % | |
|---|---|---|---|---|---|
| Vanguard S&P 500 UCITS USD Inc | IE00B3XXRP09 | 10.32 | 108.65 | -0.01% | |
| iShares EURO STOXX 50 UCITS Dist | IE0008471009 | 5.72 | 5,738.0 | -0.24% | |
| MS INVF Emerging Mkts Dbt Opps ZH EUR | LU2607332496 | 4.10 | - | - | |
| MS INVF Euro Corporate Bd - Dur Hgd Z | LU1832968926 | 3.81 | - | - | |
| Candriam Bonds Euro Short Term Class S EUR Cap | LU1184248083 | 3.26 | 1,649.010 | +0.04% |
| Type | Daily | Weekly | Monthly |
|---|---|---|---|
| Moving Averages | Buy | Buy | Buy |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
| Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review